These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11130055)

  • 21. Toll-like receptors involved in the response to microbial pathogens: development of agonists for toll-like receptor 9.
    Schetter C; Vollmer J
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):204-10. PubMed ID: 15603254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling.
    Shinohara H; Inoue A; Toyama-Sorimachi N; Nagai Y; Yasuda T; Suzuki H; Horai R; Iwakura Y; Yamamoto T; Karasuyama H; Miyake K; Yamanashi Y
    J Exp Med; 2005 Feb; 201(3):333-9. PubMed ID: 15699069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of innate immune responses by Toll-like receptors.
    Takeda K; Akira S
    Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. For whom the bug tolls.
    Goldberg J
    Trends Microbiol; 2001 Mar; 9(3):109. PubMed ID: 11239775
    [No Abstract]   [Full Text] [Related]  

  • 25. Bacterial DNA induced iNOS expression through MyD88-p38 MAP kinase in mouse primary cultured glial cells.
    Hosoi T; Suzuki S; Nomura J; Ono A; Okuma Y; Akira S; Nomura Y
    Brain Res Mol Brain Res; 2004 May; 124(2):159-64. PubMed ID: 15135224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of toll-like receptor in innate immunity].
    Takeda K; Akira S
    Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2097-102. PubMed ID: 12518420
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunology: DNA drives autoimmunity.
    Vinuesa CG; Goodnow CC
    Nature; 2002 Apr; 416(6881):595-8. PubMed ID: 11948338
    [No Abstract]   [Full Text] [Related]  

  • 28. Cultured astrocytes express toll-like receptors for bacterial products.
    Bowman CC; Rasley A; Tranguch SL; Marriott I
    Glia; 2003 Sep; 43(3):281-91. PubMed ID: 12898707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation hybrid mapping of two members of the Toll-like receptor gene family in pigs.
    Franceschi A; Cassini P; Scalabrini D; Botti S; Bandi CM; Giuffra E
    Anim Genet; 2004 Jun; 35(3):251-2. PubMed ID: 15147404
    [No Abstract]   [Full Text] [Related]  

  • 30. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6.
    Kawai T; Sato S; Ishii KJ; Coban C; Hemmi H; Yamamoto M; Terai K; Matsuda M; Inoue J; Uematsu S; Takeuchi O; Akira S
    Nat Immunol; 2004 Oct; 5(10):1061-8. PubMed ID: 15361868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptor 9 signaling can sensitize fibroblasts for apoptosis.
    Fischer SF; Rehm M; Bauer A; Höfling F; Kirschnek S; Rutz M; Bauer S; Wagner H; Häcker G
    Immunol Lett; 2005 Feb; 97(1):115-22. PubMed ID: 15626483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunology. The toll of cathepsin K deficiency.
    Krieg AM; Lipford GB
    Science; 2008 Feb; 319(5863):576-7. PubMed ID: 18239112
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunological mechanism of DNA vaccine efficacy].
    Koyama S; Kawagoe T; Akira S; Ishii K
    Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):1096-100. PubMed ID: 21089547
    [No Abstract]   [Full Text] [Related]  

  • 34. An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA.
    Krieg AM
    J Lab Clin Med; 1996 Aug; 128(2):128-33. PubMed ID: 8765208
    [No Abstract]   [Full Text] [Related]  

  • 35. CpG DNA: a novel immunomodulator.
    Krieg AM
    Trends Microbiol; 1999 Feb; 7(2):64-5. PubMed ID: 10081082
    [No Abstract]   [Full Text] [Related]  

  • 36. Harnessing innate immunity to suppress lymphoma.
    Stevenson FK; Johnson PW
    J Clin Oncol; 2010 Oct; 28(28):4295-6. PubMed ID: 20697076
    [No Abstract]   [Full Text] [Related]  

  • 37. CpG: the double-edged sword.
    Paillard F
    Hum Gene Ther; 1999 Sep; 10(13):2089-90. PubMed ID: 10498241
    [No Abstract]   [Full Text] [Related]  

  • 38. Now I know my CpGs.
    Krieg AM
    Trends Microbiol; 2001 Jun; 9(6):249-52. PubMed ID: 11390225
    [No Abstract]   [Full Text] [Related]  

  • 39. T cells: A killer cytokine.
    Bird L
    Nat Rev Immunol; 2015 Aug; 15(8):466-7. PubMed ID: 26205580
    [No Abstract]   [Full Text] [Related]  

  • 40. AIMing 2 defend against intracellular pathogens.
    Krieg AM
    Nat Immunol; 2010 May; 11(5):367-9. PubMed ID: 20404848
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.